在脓毒症中，β-内酰胺类抗生素连续输注与间歇性输注在 90 天死亡率方面没有差异。

In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d.

机构信息

National Institutes of Health, Critical Care Medicine Department, Bethesda, Maryland, USA (M.K.W., J.R.S.).

出版信息

Ann Intern Med. 2024 Sep;177(9):JC102. doi: 10.7326/ANNALS-24-01752-JC. Epub 2024 Sep 3.

Abstract

Dulhunty JM, Brett SJ, De Waele JJ, et al; BLING III Study Investigators. JAMA. 12 June 2024. [Epub ahead of print.] 38864155.

摘要

杜伦蒂 JM、布雷特 SJ、德瓦利 JJ 等人；BLING III 研究调查人员。JAMA。2024 年 6 月 12 日。[提前在线出版]。38864155.

相似文献

In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d.

Ann Intern Med. 2024 Sep;177(9):JC102. doi: 10.7326/ANNALS-24-01752-JC. Epub 2024 Sep 3.

In sepsis or septic shock, prolonged vs. intermittent infusion of β-lactam antibiotics reduces mortality at 90 d.

Ann Intern Med. 2024 Sep;177(9):JC103. doi: 10.7326/ANNALS-24-01751-JC. Epub 2024 Sep 3.

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.

Crit Care Resusc. 2019 Mar;21(1):63-68.

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.

JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779.

A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.

Crit Care Resusc. 2013 Sep;15(3):179-85.

Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis.

Crit Care Resusc. 2023 Oct 18;23(3):273-284. doi: 10.51893/2021.3.OA4. eCollection 2021 Sep 6.

Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.

JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.

Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91. doi: 10.1164/rccm.201601-0024OC.

Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.

Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9.

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.

Intensive Care Med. 2016 Oct;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0. Epub 2016 Jan 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

在脓毒症中，β-内酰胺类抗生素连续输注与间歇性输注在 90 天死亡率方面没有差异。

In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d.

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

在脓毒症中，β-内酰胺类抗生素连续输注与间歇性输注在 90 天死亡率方面没有差异。

In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d.

机构信息

出版信息

相似文献